Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22400263 | 0.97 | ALDH1A1 (0.50) | ALDH1A1CA1CA2CA9 | |
| SCHEMBL14778822 | 0.80 | CA1 (0.50) | ALDH1A1CA1CA2CA9 | |
| SCHEMBL14779468 | 0.75 | CA1 (0.39) | ALDH1A1CA1CA2CA9 | |
| SCHEMBL14778600 | 0.73 | ALDH1A1 (0.39) | ALDH1A1CA1CA2CA9 | |
| SCHEMBL560454 | 0.72 | ALDH1A1 (0.59) | ALDH1A1CA1CA2CA9 | |
| SCHEMBL6113411 | 0.72 | ALDH1A1 (0.35) | ALDH1A1CA1CA2CA9 | |
| SCHEMBL21495182 | 0.71 | ALDH1A1 (0.43) | ALDH1A1CA1CA2CA9 | |
| SCHEMBL13641273 | 0.69 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL2801206 | 0.69 | — | — | |
| SCHEMBL331716 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4206205-B1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | PRIMEGENE BEIJING CO LTD (CN) | 2026-03-04 | — | — | EP | claimed |
| US-20230303578-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | PRIMEGENE (BEIJING) CO., LTD. (CN) | 2023-09-28 | — | — | US | claimed |
| EP-4206205-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | Primegene (Beijing) Co., Ltd. (CN) | 2023-07-05 | — | — | EP | claimed |
| WO-2022042577-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | 北京普祺医药科技有限公司 | 2022-03-03 | — | — | WO | claimed |
| CN-114085224-A | Preparation method of pyrrolopyrimidine compound | 北京普祺医药科技有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-108693286-B | Method for detecting genotoxic impurity diisopropyl sulfate in medicine | 中科广化（重庆）新材料研究院有限公司 | 2020-08-07 | — | — | CN | claimed |
| CN-108693286-A | The detection method of genotoxicity impurity sulfuric acid diisopropyl ester in a kind of drug | 中科广化（重庆）新材料研究院有限公司 | 2018-10-23 | — | — | CN | claimed |
| CN-1038607-C | Post treatment technology for drawnwork fabric | UNIV HANGZHOU (CN) | 1998-06-03 | — | — | CN | claimed |
| EP-4206205-B1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | PRIMEGENE BEIJING CO LTD (CN) | 2026-03-04 | — | — | EP | disclosed |
| US-20240018110-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | ALPHA-9 ONCOLOGY INC. (CA) | 2024-01-18 | — | — | US | disclosed |
| US-20230303578-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | PRIMEGENE (BEIJING) CO., LTD. (CN) | 2023-09-28 | — | — | US | disclosed |
| EP-4206205-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | Primegene (Beijing) Co., Ltd. (CN) | 2023-07-05 | — | — | EP | disclosed |
| WO-2022042577-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | 北京普祺医药科技有限公司 | 2022-03-03 | — | — | WO | disclosed |
| CN-114085224-A | Preparation method of pyrrolopyrimidine compound | 北京普祺医药科技有限公司 | 2022-02-25 | — | — | CN | disclosed |
| CN-1320981-A | Non-aqueous electrolyte and secondary lithium cell using said electrolyte | UBE INDUSTRIES (JP) | 2001-11-07 | — | — | CN | disclosed |
| US-5717124-A | Process for preparation of oxyglutaric acid ester derivatives | UBE INDUSTRIES, LTD. (JP) | 1998-02-10 | — | — | US | disclosed |
| EP-0534044-B1 | Method for etching an aluminum foil for an electrolytic capacitor | ASAHI GLASS CO LTD (JP) | 1996-04-17 | — | — | EP | disclosed |
| EP-0534044-A1 | Method for etching an aluminum foil for an electrolytic capacitor | ASAHI GLASS COMPANY LTD. (JP) | 1993-03-31 | — | — | EP | disclosed |
| US-5194127-A | Method for etching an aluminum foil for an electrolytic capacitor | ASAHI GLASS COMPANY LTD. (JP) | 1993-03-16 | — | — | US | disclosed |
| US-5143587-A | Method for etching an aluminum foil for an electrolytic capacitor | ASAHI GLASS COMPANY LTD. (JP) | 1992-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303578-A1 | PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND | DPYD, RPLP2, DHPS | ALDH1A1 1717/4885CA1 4373/4885CA2 2538/4885 |
| US-20240018110-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | KLK3, FOLH1, TMEM14C | ALDH1A1 2048/4885CA1 882/4885CA2 2802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.